MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-16-2026
Meridian Bioscience EV - Enterprise Value 2011-2026 | VIVO
Annual EV - Enterprise Value Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.3 B | 833 M | 747 M | 488 M | 741 M | 586 M | 719 M | 719 M | 546 M | 864 M | 637 M | 568 M | -37.9 M | -54 M | -49.3 M | -49.4 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.3 B | -54 M | 535 M |
EV - Enterprise Value of other stocks in the Diagnostics research industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
45.8 B | $ 115.08 | 0.1 % | $ 35 B | USA |
 |
Celcuity
CELC
|
5.57 B | $ 134.26 | -2.87 % | $ 6.28 B | USA |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-1.92 M | $ 9.11 | 79.68 % | $ 12.1 M | USA |
 |
Castle Biosciences
CSTL
|
463 M | $ 19.69 | -2.28 % | $ 571 M | USA |
 |
Aspira Women's Health
AWH
|
10.6 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
69.5 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
Fulgent Genetics
FLGT
|
583 M | $ 17.67 | 3.27 % | $ 544 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
CareDx, Inc
CDNA
|
1.04 B | $ 21.54 | -0.42 % | $ 1.15 B | USA |
 |
Guardant Health
GH
|
15.2 B | $ 119.85 | 0.76 % | $ 15 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-2 K | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
16.3 M | $ 1.8 | -1.1 % | $ 7.96 M | USA |
 |
ICON Public Limited Company
ICLR
|
26.4 B | $ 113.85 | -2.51 % | $ 9.39 B |  Irlanda |
 |
Illumina
ILMN
|
15.3 B | $ 145.23 | 0.56 % | $ 23.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
-2.71 B | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
3.34 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
Lantheus Holdings
LNTH
|
5.9 B | $ 100.06 | -2.85 % | $ 6.75 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Charles River Laboratories International
CRL
|
11.4 B | $ 156.73 | -2.23 % | $ 7.77 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Mettler-Toledo International
MTD
|
32.1 B | $ 1 101.33 | -0.16 % | $ 22.7 B |  Schweiz |
 |
Medpace Holdings
MEDP
|
14 B | $ 429.11 | -0.85 % | $ 12.4 B | USA |
 |
NeoGenomics
NEO
|
1.85 B | $ 9.27 | 0.43 % | $ 1.19 B | USA |
 |
National Research Corporation
NRC
|
432 M | $ 19.04 | -0.21 % | $ 426 M | USA |
 |
Exact Sciences Corporation
EXAS
|
22 B | - | - | $ 19.8 B | USA |
 |
Natera
NTRA
|
5.53 B | $ 200.91 | -1.12 % | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
598 M | $ 3.85 | 0.79 % | $ 357 M | USA |
 |
Personalis
PSNL
|
380 M | $ 8.94 | 5.55 % | $ 798 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
43.5 B | $ 26.94 | -0.04 % | $ 25.5 B |  Niderland |
 |
Senseonics Holdings
SENS
|
376 M | $ 6.43 | 1.42 % | $ 268 M | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
2.13 B | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
6.63 M | $ 2.47 | -0.8 % | $ 5.67 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
33.1 B | $ 258.45 | -0.57 % | $ 21.5 B | USA |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 64.87 | 7.1 % | $ 3.88 B | USA |
 |
Thermo Fisher Scientific
TMO
|
186 B | $ 448.18 | -0.02 % | $ 169 B | USA |
 |
Waters Corporation
WAT
|
21.6 B | $ 338.64 | -1.09 % | $ 20.2 B | USA |
 |
Trinity Biotech plc
TRIB
|
327 M | $ 0.65 | 7.49 % | $ 233 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
568 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 9.14 | 2.7 % | $ 1.98 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
22.9 B | $ 192.88 | -1.19 % | $ 21.4 B | USA |